Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy - Concepedia

Concepedia

Publication | Closed Access

Effects of Troglitazone: A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy

179

Citations

0

References

1996

Year

Yasuhiko Iwamoto, Kinori Kosáka, Takeshi Kuzuya, Yasuo Akanuma, Yukio Shigeta, Toshio Kaneko

Abstract

Troglitazone at 400 mg/day decreased FPG and HbA1c significantly in NIDDM patients who had failed to respond to diet therapy. Troglitazone, developed as a drug to enhance insulin action, can be a useful hypoglycemic agent for the treatment of NIDDM.